Pharmafile Logo
Pharmafocus logo
Advanced Search

Sten Westerberg joins BioInvent

April 26, 2011
Research and Development appointment, research and development, sales and marketing

Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …

Appointment
William Weldon

Top 5 reasons for a Class I product recall

April 21, 2011
Manufacturing and Production Johnson & Johnson, product recalls

Having to recall a pharmaceutical product because of a major quality defect or safety issue is a heart sinking moment …

Feature

Digital Pharma: Boehringer UK tweets politicians with afib message

April 21, 2011
Medical Communications Boehringer Ingelheim, Digital Pharma blog, Twitter, medical communications

Boehringer Ingelheim UK is using Twitter to reach politicians with local disease awareness messages. About a third of MPs have …

News

WPP launches UK healthcare digital division

April 21, 2011
Medical Communications Ogilvy, Ogilvy Healthworld UK, OgilvyHealthPR, WPP, medical communications, ogilvy healthworld advertising

Communications giant WPP has merged the digital activities of two media brands to launch a new entity in the UK, …

News

UCB and Amgen’s osteoporosis drug shows promise

April 21, 2011
Research and Development Amgen, UCB, osteoporosis

Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …

News

Report sounds off-label prescribing warning

April 21, 2011
Sales and Marketing EAASM, off label

A pharma-backed group has warned that some ‘off-label’ prescribing is dangerous for patients. A report by the European Alliance for …

News

Trevor Smith to lead Takeda in Europe

April 21, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …

Appointment

Saving billions through ‘innovation’ – can the NHS pull it off?

April 21, 2011
NHS reforms

Innovation is not a concept immediately associated with the UK’s national health service, but is now being promoted by the …

Feature

Procurement pitfalls and hurdles of lab equipment for clinical trials

April 20, 2011
Research and Development clinical trials, medical equipment, mesm, procurement

 Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …

Feature
Thought Leadership

Eisai launches cancer drug Halaven in UK

April 20, 2011
Sales and Marketing Eisai, Halaven, breast cancer

Eisai’s sea sponge derived breast cancer drug Halaven has been launched in the UK following approval from European regulators a …

News

Novavax appoints Stanley Erck chief executive

April 20, 2011
Research and Development appointment, research and development

US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …

Appointment

Generics push US drug growth to $307bn

April 20, 2011
IMS, IMS Health, drug spending, healthcare spending

Generics replaced branded drugs as the main growth drivers for the US pharmaceutical market in 2010. The market saw just …

News

Warner Chilcott plans to axe 500 jobs in Europe

April 20, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Warner Chilcott, pharma job cuts

Warner Chilcott is looking to cut 500 jobs from its European operations as it seeks to minimise the impact of …

News

Contract research news in brief

April 20, 2011
Research and Development CRO, contract research

Our contract research news round-up features updates from BioClinica, Vyteris, CROMSOURCE, Quintiles, Imperial/D. Anderson and PRA International. Clinical trial management …

News

Life Healthcare Communications expands

April 20, 2011
Medical Communications appointment, medical communications

Life Healthcare Communications has expanded, adding new employees and extending its existing digital department.The Berkshire, UK-based creative communications agency has …

News

Circassia raises funds to develop allergy products

April 19, 2011
Research and Development Circassia, UK biotech, biotech

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …

News
Novartis Gilenya (fingolimod)

Oral MS drug Gilenya launched in the UK

April 19, 2011
Sales and Marketing Novartis, gilenya, multiple sclerosis

Gilenya has become the first oral multiple sclerosis drug to be launched in the UK. Gilenya (fingolimod) is licenced to …

News
Novartis' Afinitor (everolimus)

NICE unimpressed with Novartis’ patient access scheme

April 19, 2011
Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis

Novartis has been dealt a blow by NICE after the cost-effectiveness body finally refused to recommend, on appeal, its kidney …

News

FDA issues guidance on preventing antibiotic cross-contamination

April 19, 2011
Manufacturing and Production FDA, GMP, pharma manufacturing

The FDA has published a new guidance document to help drugmakers prevent cross-contamination of pharmaceuticals with non-penicillin beta-lactam antibiotics. The …

News

Organogenesis to build ‘largest automated living cell facility’

April 19, 2011
Manufacturing and Production Cell biology, Organogenesis, pharma manufacturing

Regenerative medicine specialist Organogenesis has started construction of an automated manufacturing facility for human cells, which it claims will be …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026